Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LXEO compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
LXEO
Lexeo Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LXEO
Lexeo Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LXEO
0
None
Shared
0
No disclosed counterparties: LXEO.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Role chip = supplier or customer
Source: SEC EDGAR
LXEO
Lexeo Therapeutics, Inc.
Change
2.92
▲
+0.38%
· post 2.92
Mkt cap
$238.3M
Revenue
—
Revenue
—
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.42
Closed
Nov 6 '26
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Nov 6 '26
LXEO
Lexeo Therapeutics, Inc.
vs
AMGN
Amgen Inc
2.92
▲
+0.38%
post 2.92
Price
460.55
▲
+0.06%
post 460.42
$238.3M
Mkt cap
$249.0B
—
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
LXEO
2.92
▲
+0.38%
vs
AMGN
460.55
▲
+0.06%
Closed
Nov 6 '26